Category:Biosimilars

From Wikipedia: A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.

Biosimilars are part of a larger class of "therapeutic equivalents"; see our page on therapeutic equivalents for more information.

More information on FDA-approved biosimilar products is available through the link to the FDA site.

Note: at this time, due to prioritization, we have de-prioritized adding literature directly related to the evaluation of biosimilars (e.g., an RCT that compares the original product to a biosimilar). We will endeavor to add these over time.